openPR Logo
Press release

“SPARKing" New Antibiotic Drug Discovery

12-04-2017 06:11 PM CET | Science & Education

Press release from: SMi Group

Superbugs and Superdrugs 2018

Superbugs and Superdrugs 2018

Kathy Talkington, Project Director from Pew Charitable Trusts, will discuss the "Shared Platform for Antibiotic Research and Knowledge" when she presents a keynote on "SPARKing" new antibiotic drug discovery at SMi’s 20th annual conference on Superbugs and Superdrugs next March in Central London.

With a background in managing and developing immunization and infectious disease programs and policies, Kathy Talkington is currently responsible for Pew’s work on antibiotics. Pew seeks to address the growing threat of antibiotic resistance by spurring the innovation of new antibiotics and ensuring the appropriate use of antibiotics in both human health care settings and in animals.

"SPARK" is a ground breaking and dynamic platform that brings together antibiotic discovery data and cutting-edge analytics to help scientists tackle the scientific barriers blocking antibiotic discovery.
While the global threat of antibiotic resistance continues to rise, nearly every antibiotic in use today is based on a discovery from more than 30 years ago. SPARK will focus on the unique challenges of finding and designing antibiotics that can defeat drug-resistant Gram-negative bacteria, which are among the hardest-to-treat superbugs.

Other presentations in the featured spotlight on the development of new therapeutics and drugs will include:

• Use of the Pasnas Platform to Enable High Quality Antibacterial Hit Finding presented by Domingo Gargallo-Viola, Chief Scientific Officer, ABAC Therapeutics
• Building a Detailed Computational Network Model of Cell Envelope Biogenesis: A Systems Biology Approach to Developing Antibacterial Drugs (Potentiators) presented by John George, CSO, Oppilotech
• Teaching Old Cephalosporin Dogs New Mechanistic Tricks against MDR Gram-Negative Bacteria Presented by Larry Sutton, Scientific Founder, Gladius Pharmaceuticals
• Novel Virulence Factors Of Acinetobacter Baumannii as Targets for Antibacterial Development presented by Daniel Zurawski, Head, Antibacterial Discovery and Development, Walter Reed Army Institute Of Research

SMi’s 20th Annual conference on Superbugs & Superdrugs will take place on 19th & 20th March 2018 at the Copthorne Tara Hotel, Kensington in London, UK.

Further details including a full speaker line-up and detailed programme are available at www.superbugssuperdrugs.com/openpr

--- end ---

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

2 Floor Harling House
47-51 Great Suffolk Street

Contact Information:
For all media enquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.uk
For exhibition and sponsorship enquires contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: amalick@smi-online.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release “SPARKing" New Antibiotic Drug Discovery here

News-ID: 844219 • Views: 413

More Releases from SMi Group

Registration is now open for the 2nd annual Wearable Injectors and Connected Dev …
SMi Reports: Registration is open for SMi Group's 2nd annual Wearable Injectors and Connected Devices Conference taking place in October. SMi's 2nd annual Wearable Injectors and Connected Devices conference will explore the latest digital applications for on-body devices through industry case studies and perspectives, advances in device design for large volume delivery, drug/device compatibility for wearable injectors and real world examples from industry thought leaders on a patient-centric approach. Furthermore, the
The British Army's ATDU to present a keynote address on Power Management at Futu …
SMi Reports: Hear from the British Army's Armoured Trials and Development Unit at Future Armoured Vehicles Power Systems Conference, taking place in London, this September The Future Armoured Vehicles Power Systems Conference, taking place on 23rd-24th September 2020 in London, UK, will provide a global meeting point to discuss efforts being made to enhance current armoured vehicle performance, as well as an exploration of the developments being made to guarantee
Jace Blackburn, Smart Device Engineer, Genentech will be presenting at the inaug …
SMi Reports: SMi Group are delighted to announce that Jace Blackburn, Smart Device Engineer, Genentech will be a speaker at the inaugural Pre-filled Syringes San Francisco Conference on September 14th and 15th, 2020. SMi Group is holding the inaugural Pre-filled Syringes San Francisco conference, taking place on the 14th and 15th September 2020, in San Francisco, USA and have confirmed Jace Blackburn, Smart Device Engineer, Genentech as a speaker. Jace Blackburn is
Airborne Technologies Webinar on Search & Rescue: From the Indian Ocean to the A …
SMi reports: Airborne Technologies to host an online webinar, taking place on Wednesday 10th June 2020. SMi Group are pleased to announce a free exclusive webinar hosted by Airborne Technologies on 'Search & Rescue: From the Indian Ocean to the Alpine Mountains. 2 SAR Case Studies: Twin Otter and AW10', taking place on the 10th June 2020 at 2pm BST (3pm CET/ 9am EDT). This is a free webinar to join.

All 5 Releases


More Releases for Superbugs

Four weeks until SMi’s 21st Annual Superbugs & Superdrugs Conference 2019
SMi Reports: Senior industry experts will gather in London to discuss the recent advances made in combating antibiotic resistance. As the global threat of antimicrobial resistance continues to grow, the advances of modern medicines are at risk of being lost. Failure to act quickly means the spread of antibiotic-resistant bacteria could lead to increased mortality from normally minor injuries and benign infections. For this reason, the Superbugs & Superdrugs conference, taking
Registration Officially Opens for the 21st Annual Superbugs & Superdrugs Confere …
As the global threat of antimicrobial resistance continues to grow, the advances of modern medicine are at risk of being lost. Failure to act quickly means the spread of antibiotic-resistant bacteria could lead to increased mortality from normally minor injuries and benign infections. SMi’s highly anticipated Superbugs & Superdrugs conference is set to return to London, UK for its 21st year running, on the 18th & 19th March 2019 (http://www.superbugssuperdrugs.com/openpr). This
Kidney Infection Market | Superbugs | CAGR 5.2% | USA | PDF | PPT | Case Reports …
Kidney infection is a result of infection in the bladder that spreads to the kidney. Most common bacteria causing kidney infection is E. coli. Kidney infections are very common, especially, an aging population. The blood test is performed to make sure that the kidneys are functioning normally. The urine test, called a urinalysis, detects any abnormal cells or proteins that relate to a kidney problem. If the blood and urine
W. J. Wiess and A.S. Lynch invitation to SMi’s Superbugs & Superdrugs USA Conf …
SMi Group reports: William J. Weiss - University of North Texas Health Science Center and Anthony Simon Lynch - Janssen supporting SMi's Superbugs & Superdrugs USA Conference, which is due to take place this November in New Jersey William and Anthony are chairing SMi's Superbugs & Superdrugs USA Conference and encourage all involved in AMR to join experts from multiple disciplines, in the field of infectious disease representing research, regulatory, funding,
Superbugs & Superdrugs USA Conference returns to New Jersey this November
SMi Group reports: agenda released for 3rd annual Superbugs & Superdrugs USA conference Building on almost two decades worth of expertise in fighting the growing threat of antimicrobial resistance (AMR), SMi Group is pleased to announce the release of the official agenda for the 3rd annual Superbugs & Superdrugs USA Conference, which is due to take place in Iselin, New Jersey on November 12 - 13, 2018. Antimicrobial resistance, leading to the
Superbugs: Exclusive Interviews Released with ABAC Therapeutics, Alchemy Biomedi …
SMI REPORTS: Expert insight into tackling the scientific, regulatory and economic challenges to combat antimicrobial resistance. It is imperative for medical experts and drug discovery specialists to stay on top of the latest clinical advancements, developments and industry initiatives related to antimicrobial resistance. For this reason, SMi Group have gathered industry experts and government bodies to share their insights at the 20th annual conference on Superbugs and Superdrugs taking place on